The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADTALEM GLOBAL ED INC | COM | 00737L103 | 166,318 | 4,685 | SH | SOLE | 4,685 | 0 | 0 | |||
VANGUARD INDEX FDS | S&P 500 ETF SHS | 922908363 | 27,542,597 | 78,393 | SH | SOLE | 78,393 | 0 | 0 | |||
VANGUARD BD INDEX FDS TOTAL BND MRKT | TOTAL BND MRKT | 921937835 | 95,334,697 | 1,327,042 | SH | SOLE | 1,327,042 | 0 | 0 | |||
VANGUARD INTL EQUITY INDEX F | TT WRLD ST ETF | 922042742 | 7,001,472 | 81,233 | SH | SOLE | 81,233 | 0 | 0 | |||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 65,300 | 48,731 | SH | SOLE | 48,731 | 0 | 0 |